In his study, Didier Hannequin carries out multidisciplinary Genetics and Locus (genetics) research. He integrates Locus (genetics) and Gene in his research. His work on PDGFRB expands to the thematically related Gene. His research on PDGFRB frequently links to adjacent areas such as Genetics. His study brings together the fields of Dementia and Disease. Didier Hannequin undertakes interdisciplinary study in the fields of Dementia and Frontotemporal dementia through his research. Frontotemporal dementia and Disease are frequently intertwined in his study. His multidisciplinary approach integrates Internal medicine and Psychiatry in his work. He connects Psychiatry with Internal medicine in his study.
His work on Alzheimer's disease expands to the thematically related Disease. He undertakes multidisciplinary investigations into Alzheimer's disease and Dementia in his work. His Dementia study frequently links to adjacent areas such as Pathology. As part of his studies on Pathology, Didier Hannequin often connects relevant areas like Frontotemporal dementia. His Frontotemporal dementia study frequently intersects with other fields, such as Disease. Didier Hannequin performs integrative study on Internal medicine and Psychiatry in his works. Didier Hannequin combines Psychiatry and Internal medicine in his studies. Didier Hannequin performs multidisciplinary study on Genetics and Allele in his works. His multidisciplinary approach integrates Allele and Genetics in his work.
In the field of C9orf72 and Primary progressive aphasia Didier Hannequin studies Frontotemporal dementia. He connects Primary progressive aphasia with Frontotemporal dementia in his research. Voxel-based morphometry and Grey matter are the subject areas of his White matter study. The Parkinson's disease portion of his research involves studies in Deep brain stimulation and Lewy body. Didier Hannequin conducted interdisciplinary study in his works that combined Lewy body and Parkinson's disease. He integrates many fields, such as Disease and Medical diagnosis, in his works. Didier Hannequin undertakes interdisciplinary study in the fields of Dementia and Neurocognitive through his research. While working in this field, he studies both Internal medicine and Physical medicine and rehabilitation. In his research, he performs multidisciplinary study on Physical medicine and rehabilitation and Internal medicine.
His study connects Cognitive decline and Dementia. Cognitive decline is closely attributed to Dementia in his research. His work on Disease is being expanded to include thematically relevant topics such as Lewy body. His Lewy body study frequently links to other fields, such as Disease. He combines Internal medicine and Physical medicine and rehabilitation in his research. Didier Hannequin combines Physical medicine and rehabilitation and Internal medicine in his studies. His study connects Asymptomatic and Pathology. He regularly ties together related areas like Pathology in his Asymptomatic studies. He integrates Oncology with Gastroenterology in his study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Jean-Charles Lambert;Jean-Charles Lambert;Jean-Charles Lambert;Carla A Ibrahim-Verbaas;Denise Harold;Adam C Naj.
Nature Genetics (2013)
Genome-wide association study indentifies variants at CLU and CR1 associated with Alzheimer’s disease
J Lambert;S Heath;G Even;D Campion.
Nature Genetics (2009)
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.
Paul Hollingworth;Denise Harold;Rebecca Sims;Amy Gerrish.
Nature Genetics (2011)
APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy
Anne Rovelet-Lecrux;Didier Hannequin;Gregory Raux;Nathalie Le Meur.
Nature Genetics (2006)
Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease.
Valentina Escott-Price;Céline Bellenguez;Li-San Wang;Seung-Hoan Choi.
PLOS ONE (2014)
Analysis of shared heritability in common disorders of the brain
Verneri Anttila;Verneri Anttila;Brendan Bulik-Sullivan;Brendan Bulik-Sullivan;Hilary K. Finucane;Raymond K. Walters;Raymond K. Walters.
Early-Onset Autosomal Dominant Alzheimer Disease: Prevalence, Genetic Heterogeneity, and Mutation Spectrum
Dominique Campion;Cécile Dumanchin;Didier Hannequin;Bruno Dubois.
American Journal of Human Genetics (1999)
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
Rebecca Sims;Sven J. Van Der Lee;Adam C. Naj;Céline Bellenguez;Céline Bellenguez.
Nature Genetics (2017)
APOE and Alzheimer disease: a major gene with semi-dominant inheritance
E Genin;D Hannequin;D Wallon;K Sleegers.
Molecular Psychiatry (2011)
A Polymorphism in CALHM1 Influences Ca2+ Homeostasis, Aβ Levels, and Alzheimer's Disease Risk
Ute Dreses-Werringloer;Jean Charles Lambert;Valérie Vingtdeux;Haitian Zhao.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: